［1］ Fujisawa C，Castellot JJ Jr. Matrix production and remodeling as therapeutic targets for uterine leiomyoma［J］. J Cell Commun Signal，2014，8（3）：179-194.［2］ Turan V，Bedoschi G，Moy F，et al. Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients［J］. Fertil Steril，2013，100（6）:1681-1685.［3］ Duhan N，Madaan S，Sen J. Role of the aromatase inhibitor letrozole in the management of uterine leiomyomas in premenopausal women［J］. Eur J Obstet Gynecol Reprod Biol，2013，171（2）：329-332.［4］ Gurates B，Parmaksiz C，Kilic G，et al. Treatment of symptomatic uterine leiomyoma with letrozole［J］. Reprod Biomed Online，2008，17（4）:569-574.［5］ Gurates B,Pramaksiz C,Kilic G,et al.Treatment of symptomatic uterine leiomyoma with letrozole［J］.Reprod Biomed Online,2008,17(4):569-574.［6］ Mitwally M，Casper R．The ammatase inhibitor，letroole：a promising altemative for clomiphene citrate for induction of ovulation［J］．Fertil Steril，2000，74(3)：535．［7］ Shozu M，Murakami K，Segawa T，et al. Successful treatment of a symptomatic uterine leiomyoma in a perimenopausal woman with a nonsteroidal aromatase inhibitor［J］. Fertil Steril，2003，79（3）: 628-631.［8］ Kar S. Current evidence supporting "letrozole" for ovulation induction［J］. J Hum Reprod Sci，2013，6（2）:93-98.［9］ 李卫平，陈珠萍，严隽鸿，等. 米非司酮、促性腺激素释放激素类似物与他莫昔芬治疗子宫肌瘤的临床疗效比较［J］.上海医学，2002，25（2）:117.［10］ 王雅芹，李美蓉.来曲唑对子宫肌瘤细胞体外增生的作用［J］.肿瘤研究与临床，2009，4（21）：242.（2015-01-01收稿 2015-03-22 修回）
